InVivo Therapeutics Holdings Corp. (NVIV) |
|
1.41 -0.02 (-1.4%)
|
02-22 16:00 |
|
Open: |
1.44 |
Pre. Close: |
1.43 |
|
High:
|
1.44 |
Low:
|
1.39 |
|
Volume:
|
38,248 |
Market Cap:
|
14M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.443 - 1.451 |
1.451 - 1.46 |
|
Low:
|
1.367 - 1.376 |
1.376 - 1.386 |
|
Close:
|
1.393 - 1.409 |
1.409 - 1.426 |
|
|
|
Technical analysis |
as of: 2019-02-22 4:45:30 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 1.89 One year: 2.09 |
| Support: |
Support1: 1.34 Support2: 1.11 |
| Resistance: |
Resistance1: 1.62 Resistance2: 1.79 |
| Pivot: |
1.48 |
| Moving Average: |
MA(5): 1.43 MA(20): 1.52
MA(100): 1.79 MA(250): 4.46 |
| MACD: |
MACD(12,26): -0.05 Signal(9): -0.05 |
| Stochastic oscillator: |
%K(14,3): 23.93 %D(3): 23.34  |
| RSI: |
RSI(14): 37.97 |
| 52-week: |
High: 24.50 Low: 1.34 Change(%): -88.3 |
| Average Vol(K): |
3-Month: 5659 10-Days: 4395 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.NVIV has closed above bottom band by 24.3%. Bollinger Bands are 28.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 17 Jan 2019 21:29:38 Z
Consumer Sector Update for 01/17/2019: FOSL,GOOG,GOOGL,PPG,ADM,SIG
Thu, 17 Jan 2019 19:28:55 Z
Consumer Sector Update for 01/17/2019: PPG,ADM,SIG
Mon, 26 Nov 2018 20:13:00 Z
NVIV Hopes To INSPIRE, SENS Making Sense, TYME To Report Phase 2 Data In Jan.
Thu, 21 Jun 2018 20:11:37 Z
Mid-Afternoon Market Update: Barnes & Noble Education Climbs Following Q4 Results; InVivo Therapeutics Shares Plunge
Thu, 21 Jun 2018 18:41:37 Z
Mid-Day Market Update: Dow Down Over 150 Points; CASI Pharmaceuticals Shares Spike Higher
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
9.31 |
| Shares Float (M) |
|
|
% Held by Insiders
|
|
|
% Held by Institutions
|
5.90 |
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-14.490 |
|
EPS Est. Current Year
|
-0.780 |
|
EPS Est. Next Year
|
-0.640 |
|
EPS Est. Next Quarter
|
-0.170 |
|
Forward EPS
|
-0.460 |
|
Book Value (p.s.)
|
0.730 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-128.2 |
|
Return on Equity (ttm)
|
-156.9 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-13.43 |
|
Levered Free Cash Flow (M)
|
-8.09 |
Stock Valuations |
|
P/E
|
-0.10 |
|
P/E Growth Ratio
|
-0.01 |
|
P/BV
|
1.93 |
|
P/S
|
|
|
P/CF
|
-0.98 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2018-04-17 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
